VIR — Vir Biotechnology Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Vir Biotechnology Inc (VIR), worth $11.49M combined. Over the quarter 2 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $10.36M | 0.01% | +33.6% |
| BIT | $815.20K | 0.03% | +166.7% |
| Quadrature | $312.79K | 0.00% | -59.4% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.